BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/14/2026 4:49:26 AM | Browse: 24 | Download: 48
 |
Received |
|
2025-11-17 04:41 |
|
Peer-Review Started |
|
2025-11-17 07:25 |
|
First Decision by Editorial Office Director |
|
2025-11-19 10:15 |
|
Return for Revision |
|
2025-11-19 10:15 |
|
Revised |
|
2025-12-01 13:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-23 02:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-23 04:02 |
|
Articles in Press |
|
2025-12-23 04:02 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-28 03:34 |
|
Publish the Manuscript Online |
|
2026-03-14 04:49 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Case Report |
| Article Title |
Five-year follow-up sustained remission with rituximab in a patient with focal segmental glomerulosclerosis: A case report
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ana Flávia Moura, Paulo Novis Rocha, Daniela Moura-Landim, Jose A Moura Jr and José A Moura-Neto |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ana Flávia Moura, Department of Medicine, Bahiana School of Medicine and Public Health, Av D. Joao VI, Salvador 40290-000, Bahia, Brazil. anaflaviapsouza@gmail.com |
| Key Words |
Glomerulonephritis; Glomeruloesclerosis; Focal segmental glomerulosclerosis; Proteinuria; Rituximab; Case report |
| Core Tip |
This case report describes a patient with steroid- and calcineurin inhibitor-dependent primary focal segmental glomerulosclerosis (FSGS) who achieved complete and sustained remission for five years following a two-dose regimen of rituximab (RTX). The case highlights the potential of RTX as a steroid- and calcineurin inhibitor-sparing agent in adult FSGS, particularly in patients with significant toxicity or dependence on standard immunosuppressive therapy. The extended follow-up adds valuable insight into the long-term efficacy and safety of RTX in this challenging population. |
| Publish Date |
2026-03-14 04:49 |
| Citation |
Moura AF, Rocha PN, Moura-Landim D, Moura Jr JA, Moura-Neto JA. Five-year follow-up sustained remission with rituximab in a patient with focal segmental glomerulosclerosis: A case report. World J Nephrol 2026; 15(1): 116620 |
| URL |
https://www.wjgnet.com/2220-6124/full/v15/i1/116620.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v15.i1.116620 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
